Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy.
about
Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancerSingle nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results?Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients.ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy.
P2860
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@ast
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@en
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@nl
type
label
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@ast
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@en
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@nl
prefLabel
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@ast
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@en
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@nl
P2093
P2860
P356
P1476
Bladder preservation in muscle ...... surgery and radiochemotherapy.
@en
P2093
P2860
P356
10.1002/SSU.1013
P577
2001-01-01T00:00:00Z